These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
167 related items for PubMed ID: 27055943
1. The role of the equatorial ligands for the redox behavior, mode of cellular accumulation and cytotoxicity of platinum(IV) prodrugs. Göschl S, Varbanov HP, Theiner S, Jakupec MA, Galanski MS, Keppler BK. J Inorg Biochem; 2016 Jul; 160():264-74. PubMed ID: 27055943 [Abstract] [Full Text] [Related]
2. Optimization of axial ligands to promote the photoactivation of BODIPY-conjugated platinum(IV) anticancer prodrugs. Yao H, Gunawan YF, Liu G, Tse MK, Zhu G. Dalton Trans; 2021 Oct 12; 50(39):13737-13747. PubMed ID: 34519297 [Abstract] [Full Text] [Related]
4. Cellular trafficking, accumulation and DNA platination of a series of cisplatin-based dicarboxylato Pt(IV) prodrugs. Ravera M, Gabano E, Zanellato I, Bonarrigo I, Alessio M, Arnesano F, Galliani A, Natile G, Osella D. J Inorg Biochem; 2015 Sep 12; 150():1-8. PubMed ID: 26042542 [Abstract] [Full Text] [Related]
5. Fluorogenic platinum(IV) complexes as potential predictors for the design of hypoxia-activated platinum(IV) prodrugs. Marsh JW, Hacker L, Huang S, Boulet MHC, White JRG, Martin LAW, Yeomans MA, Han HH, Diez-Perez I, Musgrave RA, Hammond EM, Sedgwick AC. Dalton Trans; 2024 Sep 10; 53(35):14811-14816. PubMed ID: 39169877 [Abstract] [Full Text] [Related]
6. Mono- and di-bromo platinum(IV) prodrugs via oxidative bromination: synthesis, characterization, and cytotoxicity. Xu Z, Wang Z, Yiu SM, Zhu G. Dalton Trans; 2015 Dec 14; 44(46):19918-26. PubMed ID: 26514681 [Abstract] [Full Text] [Related]